Growth Metrics

TELA Bio (TELA) EBITDA Margin (2018 - 2026)

TELA Bio's quarterly EBITDA Margin came in at 64.43% in Q1 2026, down 361.0% year-on-year from 24.68% in Q1 2025, and down 48.71% quarter-over-quarter from 43.32% in Q4 2025.

TELA Bio has reported EBITDA Margin for 9 years, with the latest figure at 64.43% in Q1 2026.

  • For the quarter ending Q1 2026, EBITDA Margin fell 361.0% year-over-year to 64.43%; the trailing twelve-month figure through Mar 2026 stood at 49.31% (up 1170.0% YoY), and the FY2025 full-year result was 48.37%, up 623.0% from the prior year.
  • EBITDA Margin for Q1 2026 stood at 64.43%, down from 43.32% in the prior quarter.
  • The five-year high for EBITDA Margin was 34.06% in Q1 2024, with the low at 119.6% in Q1 2022.
  • Average EBITDA Margin over 5 years is 69.84%, with a median of 72.46% recorded in 2023.
  • Year-over-year, EBITDA Margin soared 6718 bps in 2024 and plunged 2676 bps in 2025.
  • Tracing TELA's EBITDA Margin over 5 years: stood at 81.22% in 2022, then grew by 6 bps to 76.09% in 2023, then soared by 31 bps to 52.51% in 2024, then climbed by 17 bps to 43.32% in 2025, then sank by 49 bps to 64.43% in 2026.
  • The last three EBITDA Margin figures came in at 64.43% (Q1 2026), 43.32% (Q4 2025), and 41.59% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 12.05%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 15.55%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 16.24%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 21.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 28.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 14.52%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 21.42%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 10.04%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.94%
10 TELA Bio 13.26 Mn -26.28 Mn 12.52 Mn -64.43%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -64.43%
Dec 31, 2025 -43.32%
Sep 30, 2025 -41.59%
Jun 30, 2025 -49.12%
Mar 31, 2025 -60.82%
Dec 31, 2024 -52.51%
Sep 30, 2024 -54.44%
Jun 30, 2024 -78.30%
Mar 31, 2024 -34.06%
Dec 31, 2023 -76.09%
Sep 30, 2023 -72.46%
Jun 30, 2023 -74.69%
Mar 31, 2023 -101.24%
Dec 31, 2022 -81.22%
Sep 30, 2022 -85.02%
Jun 30, 2022 -98.38%
Mar 31, 2022 -119.60%
Dec 31, 2021 -91.40%
Sep 30, 2021 -94.29%
Jun 30, 2021 -96.73%
Mar 31, 2021 -123.69%
Dec 31, 2020 -119.06%
Sep 30, 2020 -129.17%
Jun 30, 2020 -147.31%
Mar 31, 2020 -193.05%
Dec 31, 2019 -134.64%
Sep 30, 2019 -117.42%
Jun 30, 2019 -130.18%
Mar 31, 2019 -180.58%
Dec 31, 2018 -304.53%
Sep 30, 2018 -126.85%